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Developmental patterns of PDGF B-chain, PGDF-receptor, and a-actin
expression In human glomerulogenesis. Expression of PDGF B-chain
and the PDGF receptor 13-subunit (PDGFRj3) is detected immunocy-
tochemically during the development of glomeruli in human kidneys of
54 to 105 days gestational age. During the early stages (vesicular,
comma-shape and S-shape) of glomerulogenesis, PDGF B-chain is
localized to differentiating epithelium of the glomerular vesicle, while
PDGFRI3 is expressed in the undifferentiated metanephric blastema,
vascular structures, and interstitial cells. During this stage PDGF may
be acting as a paracrine growth factor and as a chemoattractant acting
to recruit mesangial progenitor cells into the developing glomerulus. As
the glomerular tuft forms, both PDGF B-chain and PDGFRI3 can be
detected in an arboreal pattern radiating from the hilus of the glomerular
tuft. Immunocytochemical studies using markers specific to endothe-
hum (Ulex europaeus I lectin, Factor VIII related antigen), and smooth
muscle (a-smooth muscle actin), indicate that the PDGF B-chain and
PDGFRI3 are both expressed primarily by mesangial cells, During this
stage, PDGF may be acting primarily to provide an autocrine factor to
mediate further mesangial cell proliferation. Glomerular expression of
a-smooth muscle actin is limited to later stages of glomerulogenesis; at
these stages the pattern of expression is similar to that of PDGF-B chain
and PDGFR/3. The upregulation of mesangial PDGF, PDGFRI3, and
a-smooth muscle actin expression that has been identified in some
disease states in both humans and experimental animals appears to
represent a recapitulation of this normal developmental process.
The development and maturation of the mammalian glomer-
ulus progresses through orderly stages beginning with differen-
tiation from metanephric blastema and proceeding through
"vesicle," "comma-shape," "S-shape" and fully differentiated
glomerular stages [reviewed in 1—31. Relatively little is known
about the molecules that influence the multiple events involved
in this process of cell proliferation, differentiation and matura-
tion. Recent studies have identified potential roles for specific
matrix proteins (such as laminin) [4], matrix-binding integrins
[5, 6], and cell adhesion molecules (N-CAM [7, 8], uvomorulin
[9]) in modulating specific segments of the developmental
sequence. The role for peptide growth factors has been ad-
dressed in studies which implicate insulin like growth factor I
and II (IGF) [10], epidermal growth factor (EGF) [11], and
transforming growth factor a (TGFa) [121 in this process, but,
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as recently reviewed by Brenner, a complete understanding of
the importance of these molecules is not yet at hand [13].
Platelet-derived growth factor (PDGF) is a covalent dimer of
two subunit chains designated A-chain and B-chain, which
exists in three naturally occurring isofonns (that is, PDGF-AA,
PDGF-AB and PDGF-BB). PDGF binds to cells via cell surface
receptors which function as noncovalent dimers of two sub-
units, designated as PDGF receptor a-subunit (PDGFRa) and
the PDGF receptor 13-subunit (PDGFR/3), in such a way that
cells expressing only PDGFRJ3 are able to bind only PDGF-BB
and cells expressing PDGFRa are able to bind all forms of
PDGF [14]. PDGF has been shown to be mitogenic for a variety
of cell types, including smooth muscle cells, glomerular mesan-
gial cells, and fibroblasts [15, 16]. PDGF may also function as a
chemotactic factor for these cells as well as for neutrophils and
monocytes. PDGF was originally isolated from platelets and
was proposed to play a role in promoting connective tissue cell
proliferation at sites of tissue damage and consequent platelet
degranulation [151. Although delivery of PDGF via platelets is
still considered to be an important source of PDGF, many other
cell types are also induced to synthesize PDGF A-chain and
B-chain under pathological conditions associated with cell
proliferation (such as, traumatic injury, inflammation, tumori-
genesis) and it has been proposed that this locally produced
PDGF plays a role in initiating or maintaining this proliferation
[15].
One type of tissue injury where PDGF may play a major role
is in glomerulonephritis. Several cell types present in an injured
glomerulus may release PDGF, including renal endothelial
cells, mesangial cells, infiltrating macrophages and platelets. In
both experimental and human proliferative glomerulo-
nephridites, PDGF and PDGF receptors have been shown to be
upregulated [17—20]. A particularly dramatic example is the
mesangial proliferative nephritis induced in rats with antibody
to the Thy-i antigen [17, 18]. The levels of PDGF B-chain and
PDGFRI3 increase more than eightfold at a time when mesangial
cells are proliferating rapidly [17, 18]. Infusion of a blocking
antibody against PDGF inhibits about 60% of this proliferation
at day 4 after disease induction [21], a time when mesangial cell
production of PDGF appears to be the principal source of this
factor. This is consistent with the hypothesis that the prolifer-
ation is driven in part by autocrine production of PDGF by the
mesangial cells in conjunction with an enhanced ability to bind
PDGF-BB.
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Although much less is known about possible roles of PDGF in
embryonic development, there is some indication that the
PDGF/PDGF receptor system may also be involved in devel-
opmental processes. PDGFRa is expressed by the mesoderm
from the time that it can first be identified as a distinct germ
layer, and continues to be expressed by a subset of mesodermal
derivatives [22]. Mouse embryos which are homozygous for a
deletion of the PDGF receptor a-subunit [23] display multiple
mesodermal abnormalities and die before birth [22]. By con-
trast, PDGFR/3 (which is the form of the receptor which seems
to be induced in a number of adult disease states) cannot be
detected in extracts of whole mouse embryos until later in
development [24], nor is the identity of the embryonic cells
expressing this receptor known. In the present study, we report
that PDGF B-chain and PDGFR/3 are expressed by the imma-
ture glomerulus at specific stages of development. To identify
the cells expressing PDGF receptor /3-subunit we have em-
ployed immunocytochemical markers of endothelium [Factor
Vill-related antigen (F111), Ulex europaeus I lectin] and the
smooth muscle-like glomerular mesangial cells (a-smooth mus-
cle actin). We report that the pattern of expression of a-smooth
muscle actin and of PDGF B-chain and PDGFR/3 in differenti-
ated fetal glomeruli closely resembles the pattern seen in
response to mesangial injury and speculate on the roles that
PDGF may be playing in these processes.
Methods
Source of tissue
Human fetal kidneys (N = 44) were obtained fresh from
tissue examined after therapeutic abortions. Fifteen of these
(estimated gestational age ranging from 54 to 105 days) were
fixed in methyl Carnoy's (methacarn) solution (60% methanol,
30% chloroform, 10% acetic acid) and processed and embedded
in paraffin according to conventional techniques. Twenty-five
kidneys (estimated gestational age ranging from 54 to 105 days)
were fixed overnight in cold 2% or 4% paraformaldehyde in
phosphate buffer, transferred to 30% sucrose in 0.01 M phos-
phate buffer, equilibrated overnight at 4°C, and snap frozen in
OCT compound (Miles, Inc., Elkhart, Indiana, USA). Four
kidneys (estimated gestational age ranging from 57 to 84 days)
were fixed overnight in cold periodate-lysine-paraformaldehyde
(PLP) solution, washed, dehydrated through 90% ethanol,
embedded in LR White resin (Ted Pella, Inc., Redding, Cali-
fornia, USA), and polymerized overnight at 55°C.
Immunohistochemis try
Sections of methyl Carnoy's fixed tissue were deparaffinized
with xylene and graded ethanols, blocked with 3% hydrogen
peroxide, and washed with PBS (138 mM) NaCI, 2.7 mri KCI,
3.2 m Na2HPO4, 1.5 m KH2PO4, pH 7.3). The tissue was
then incubated with one of the primary murine monoclonal
antibodies (see below), and subsequently processed using a
streptavidin-biotin immunoperoxidase method with 3,3'-diami-
nobenzidine (with nickel chloride enhancement) as the chro-
mogen. Sections were counterstained with methyl green.
Frozen sections of 2% or 4% paraformaldehyde fixed tissue
were hydrated in PBS, blocked with 3% hydrogen peroxide and
washed in PBS. The sections were incubated overnight at 4°C
with antibody 7212, washed, and subsequently processed as
above using a streptavidin-biotin immunoperoxidase method,
counterstained with methyl green, dehydrated and cover-
slipped.
For all samples, a negative control consisted of substitution
of the primary antibody with both irrelevant murine monoclonal
antibodies, non-immune rabbit sera in the case of Factor VIII
related antigen, and PBS. Isotype-matched irrelevant murine
antibodies were specifically utilized as controls for PDGF
B-chain, PDGFRI3, and smooth muscle a-actin. Positive inter-
nal controls in each biopsy consisted of actin-positive smooth
muscle cells comprising the renal vasculature for the a-SM-i
antibody and arterial endothelial cells for Ulex lectin and
anti-Factor VIII related antigen antibodies.
Antibodies
PDGF B-chain. Murine monoclonal antibody PG7-007 (pro-
vided by R. Ross and Mochida Pharmaceutical, Tokyo, Japan)
has been previously characterized and its ability to specifically
recognize PDGF B-chain in methacarn fixed tissue has been
demonstrated [25, 26]. The specificity of the immunohistochem-
ical reactivity of this antibody has been demonstrated in cell
culture where its activity has been abolished by pre-incubation
with immunizing PDGF peptide [25] and by studies by our
group which tightly link increased expression of the PDGF
peptide as recognized by this antibody in tissue sections with
increased synthesis of mRNA encoding PDGF as detected by
Northern analysis and in situ hybridization in rat glomeruli [17,
18].
PDGFRp. Murine monoclonal antibody PR7212 has been
previously characterized by Western blotting and competitive
binding studies and shown to recognize the /3 subunit of the
PDGF receptor [14, 27]. We have shown that this antibody
recognizes PDGFRI3 but not PDGFRa in extracts of BHK cells
transfected with the human a or /3 subunits by Western blotting
techniques. The epitope recognized by this antibody is stable in
paraformaldehyde and PLP but not methacarn fixed tissues.
Smooth muscle a-actin isoform. Murine monoclonal anti-
body a-SM-i (gift of G. Gabbiani, now commercially available
through DAKO Corp., Carpinteria, California, USA) has been
characterized by tissue immunohistochemistry and Western
blotting [28] and has been previously demonstrated to recognize
smooth muscle a-actin in methacarn-fixed tissues [29, 30]. We
have previously demonstrated the specificity of the increased
glomerular expression of a-smooth muscle actin expression
detected by tissue immunohistochemistry with this antibody by
concurrent Northern analysis for a-actin mRNA synthesis in
isolated glomeruli obtained in a rat model of mesangiolytic
injury [29].
Muscle-spec/fic actin. Antibody HHF-35 (gift of Allen Gown,
commercially available through DAKO Corp.) has been shown
to recognize the four muscle specific isoforms of actin (smooth
muscle a- and y-actin, striated muscle a-actin, cardiac muscle
a-actin, but not cytoplasmic /3 and a actins) [31] and was used
as previously described [29, 30].
Smooth muscle (desmin). A murine monoclonal antibody to
human desmin (DAKO Corp.) was used as previously described
[32].
Endothelial cells. Rabbit anti-human Factor VIII related
antigen/von Willebrand Factor (DAKO Corp.) was used as
previously described [33]. Endothelial cells were also identified
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by lectin binding studies using Ulex europaeus I lectin (Vector
Laboratories, Burlingame, California, USA) as previously de-
scribed [34, 35].
Proliferating cell nuclear antigen (PCNA). 19A2, a murine
monoclonal antibody to PCNA/cyclin (Coulter Corp., Hialeah,
Florida, USA) was used as previously described [36].
Immunoelectronmicroscopy
Frozen, 4% paraformaldehyde fixed kidneys were sectioned
at 6 pm and sections adhered to gelatin coated slides and air
dried for 30 minutes. The sections were then stained by
hydrating in PBS for 15 minutes, incubated in 0.02 M periodic
acid in PBS to inactivate endogenous peroxidase and then
incubated with normal horse serum in PBS containing 2% BSA
(Sigma, St. Louis, Missouri, USA) for 30 minutes at room
temperature to block nonspecific staining. Sections were then
incubated with either antibody PR7212 or a-SM-i at 4 pg/ml in
PBS/BSA overnight at 4°C, and rubsequently processed using a
streptavidin-biotin immunoperoxidase method with 3,3'-diami-
nobenzidine (DAB) as the chromogen and horse anti-mouse
antisera as the secondary detecting antibody system. Sections
were reacted with 1% 0s04 in phosphate buffer for one hour at
room temperature, rinsed and then dehydrated through graded
ethanols and into propylene oxide. Sections were then infil-
trated with a 50/50 mixture of PolyBed (PolySciences, Inc.,
Warrington, Pennsylvania, USA) and propylene oxide for one
hour. Beem capsules were filled with PolyBed, inverted over
the sections, infiltrated overnight and then polymerized at 55°C
for 48 hours. The blocks were removed by heating the slide
briefly and quickly snapping off the capsule. Thin, 0.1 micron
sections were cut and mounted on formvar coate nickel grids
and examined in a Philips 410 electron microscope.
Alternately, in efforts to improve preservation of morpho-
logic detail, renal tissue fixed in PLP solution, was processed
and embedded in LR white resin (Polysciences, Inc.). Thin
sections were incubated with antibody a-SM-I or control irrel-
evant monoclonal antibody overnight at 4°C, rinsed with PBS,
and subsequently incubated with goat anti-mouse IgG conju-
gated to gold (10 nm particles) as previously described [29].
Results
Kidney tissue was obtained at gestational ages of 54 to 105
days. Kidneys from the earliest gestational ages studied (ap-
proximately 54 to 65 days) typically contain metanephric blast-
ema, ureteric buds, interstitial tissue, several layers of imma-
ture glomeruli, and virtually no detectable structures
resembling mature tubules, collecting ducts, medulla or an
organized arterial or venous system. Kidneys obtained from
older fetuses typically contain metanephric blastema, intersti-
tium, ureteric buds, and glomeruli exhibiting all stages of
development ranging from earliest vesicles to apparently fully
differentiated, albeit immature, structures with identifiable
mesangium, capillary loops, and visceral and parietal epithelial
cells. A representative histologic section from such a kidney is
shown in Figure 1. Also present in later kidneys are identifiable
tubular segments, developing medulla, renal pelvis with urothe-
hal lining, and distinct arterial and venous structures.
Immunohistochemistry
The immunohistochemical findings in glomeruli of this study
are summarized in Table 1.
PDGF B-chain. Two developmental stage-specific patterns of
PDGF B-chain expression in developing glomeruli were identi-
fied. B-chain could be first identified at the earliest stages of
glomerular development, at or immediately following the vesi-
cle stage, when the differentiating epithelium of the immature
glomerulus is still in close contact with the inductive differen-
tiating stimulus, the ureteric bud (Fig. 2A, B). In addition, the
nascent parietal epithehium lining the future urinary space also
expresses PDGF B-chain. In contrast, there is no detectable
expression by the blastema or interstitial tissue. The ureteric
bud was most often negative, but occasional staining for PDGF
B-chain at the luminal surface of the ureteric bud was seen.
In later stages of glomerular development, PDGF B-chain is
expressed in an arboreal pattern radiating from the hilus of the
glomerular tuft, suggesting a mesangial origin (Fig. 2C). Extra-
glomerular structures showing expression of this protein in-
clude some immature tubules (segments distinct from ureteric
structures and with features suggesting they are in contiguity
with the still positive parietal epithelium, indicating proximal
tubule lineage), and the superficial layers of the urotheium
lining the renal pelvis and ureters.
PDGFRp. Unlike PDGF B-chain, PDGFRI3 was not detected
in the glomerulus during the early stages of differentiation.
Outside of the glomerulus, PDGFR/3 is expressed abundantly in
the metanephric blastema, and in vascular structures and inter-
stitial cells which are seen as arcades in the most immature and
superficial areas of the developing cortex (Fig. 2D). Glomerular
expression of PDGFRf3 occurs in later stages of development,
where it localizes in a mesangial pattern (Fig. 2E, F). Occasion-
ally, expression of PDGFR/3 appeared to extend to the endo-
thelium lining peripheral glomerular capillary walls (Fig. 2F). In
adjacent maturing portions of the cortex PDGFR/3 continued to
be expressed by interstitial cells and arterial vessels.
Smooth muscle cell markers/mesangial cell markers. No
specific markers that identify mesangial cells in tissue sections
currently have been identified. However, a-smooth muscle
actin, a marker for smooth muscle cells, has been shown to be
an inducible marker of activated mesangial cells in disease
states in adult rat and human glomeruli [29, 30]. Using an
antibody to this smooth muscle marker, as well as antibodies to
two additional muscle markers, pan-muscle actin and desinin,
the expression of these "muscle-specific" proteins in glomeru-
lar development was studied.
Developing glomeruhi show a gradient of expression of
a-smooth muscle actin, ranging from absent in the earliest
stages of development, to pronounced mesangial expression in
more mature glomeruli (Fig. 3A, B). The results with the
antibodies to both a-smooth muscle actin and muscle-specific
actin were identical, with the only notable difference being
somewhat stronger staining intensity obtained with the a-SM-i
antibody. The onset of smooth muscle actin expression by
mesangial cells in the course of glomerular development coin-
cided with the identification of an organized intraglomerular
vasculature having contiguity with the extraglomeruiar intersti-
tial vasculature (as detected by staining for Factor VIII related
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Fig. 1. Low power micrograph of human fetal kidney (approximately 86 days gestation). Immediately beneath the renal capsule is the
undifferentiated metanephric blastema (B). Invading the blastema from below are multiple profiles of ureteric buds (U), and occasional aggregates
of differentiating cells adjacent to the ureteric buds, the early glomerular vesicles (GV), can be identified. Glomeruli in zone of glomerulogenesis
(within brackets) show progressive differentiation from vesicle stage, to early comma and S-stages (EG), and culminating in fully differentiated
structures (G). PAS, 50x.
antigen and Ulex I lectin). There was also prominent extraglo-
merular expression of actin by differentiated smooth muscle
cells of the arterial and arteriolar vasculature, but not by other
cells comprising the interstitium.
Desmin could be identified in the smooth muscle cells com-
prising the media of muscular arteries present in the developing
renal hilus. In contrast to the muscle specific actins, there was
no localization of desmin in glomeruli at any stage of develop-
ment, and no expression of this protein detectable by the
antibody utilized in this study by metanephric blastema or the
interstitium.
Endothelial cell markers. Factor Vill-related antigen could
be identified in the aggregate of interstitial and vascular cells
invaginating into the glomerular epithelium at the comma and
S-shape stages of development. In more mature glomeruli, this
pattern of localization evolved to a predominantly mesangial
pattern similar to that of PDGF B-chain, PDGFRI3, and
a-smooth muscle actin, as seen in Figure 3C. Extraglomerular
staining was confined to the endothelial lining of the vascula-
ture.
Binding of the Ulex Europaeus I lectin showed patterns of
reactivity similar to Factor Vill-related antigen in the early
stages of glomerulogenesis and in the extra-glomerular vascu-
lature. More mature glomeruli showed discrete staining of the
endothelial lining of glomerular capillaries, but did not show the
apparent mesangial staining seen in the studies of Factor
Vill-related antigen (Fig. 3D).
Cell proliferation. Staining for the proliferation marker
PCNA was most heavily concentrated in the nephrogenic zone
in the first stages of glomerular epithelial differentiation, where
at times virtually every cell in differentiating vesicles, comma
and S-shaped glomeruli could be shown to be actively replicat-
ing as evidenced by PCNA expression (Fig. 3E). The surround-
ing blastema also showed a high replicative rate. There was a
decreasing gradient of PCNA expression corresponding to
progressively greater glomerular maturation, in distinct con-
trast to the patterns of PDGFRI3 and actin expression, although
even the most mature glomeruli continued to exhibit some
replicative activity.
Immunoelectronmicroscopy
PDGFRI3. In relatively mature glomeruli, reaction product
indicative of PDGFRI3 localization was confined to the mem-
branes of cells present in mesangial locations (Fig. 4). No
expression was detected in peripheral portions of glomerular
capillary loops where only endothelial cells or visceral epithelial
cells would be expected to be present. When endothelial cell
bodies could be identified overlying the portion of mesangium
adjacent to the capillary lumina, PDGFR could be localized to
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Table 1. Phenotypic characterization of stages of glomerulogenesis in
human fetal kidney
Metanephnc
blastema Vesicle
Early glomerular
differentiation
(comma, S-
stage)
Differentiated
glomerulus
PDGF B-chain — focal" + mesangium
PDGFR/3 + — — mesangium
a-smooth muscle — mesangium
actin
Desmin - - - -
Factor VIII capillaries mesangium'
related antigen! endothelium"
von Willebrand
factor
Ulex lectin capillaries capillary
endothelium
Expression of PDGF, its receptor, and differentiation markers of
mesenchymal cell components of the glomerulus at the principal stages
of glomerulogenesis.
Symbols are:
a Components of vasculature present in blastema and interstitium
express these markers.b j remains unresolved whether there is focal expression of PDGF in
some early vesicular elements or whether these areas represent tangen-
tial sections through portions of later developing comma or S-stage
vesicles; uncertainty whether Factor VIII related antigen expression is
limited to endothelium or may be present in fetal mesangium is
presented in the text.
PDGF—platelet-derived growth factor, PDGFRI3—platelet-derived
growth factor (/3 subunit).
the mesangial cell borders, but not those of the endothelial
cells. Because of the requirement for gentle fixation to preserve
the antigenicity of the epitope recognized by the antibody to
PDGFRI3, morphologic preservation of tissue was compro-
mised to some degree, allowing confident localization of reac-
tion product only in the anatomically well-defined structures of
relatively mature glomeruli.
Muscle-specific actin (a-SM-i). The peroxidase label indicat-
ing presence of muscle-specific actin was concentrated predom-
inantly within the cytoplasm of cells in mesangial areas identical
in appearance and location to those showing staining of the cell
membranes for PDGFR/3 (Fig. 5). Morphologic preservation of
tissues fixed in paraformaldehyde or PLP solution were both
inadequate to determine whether the peroxidase or gold labels
were localized to specific microfilament bundles.
Discussion
In this study, we have employed immunohistochemical tech-
niques to study expression and distribution of PDGF B-chain,
the PDGF receptor /3-subunit, and markers of mesenchymal cell
types in order to determine the developmental sequence and
pattern of expression and provide some insight into how the
PDGF system might be involved in human kidney development.
All sections were from normal human fetal kidneys obtained
from elective therapeutic abortions at estimated gestations of 54
to 105 days. During this developmental period, human kidneys
display a gradient of differentiation from undifferentiated blast-
ema at the outer margin of the cortex to relatively mature
glomeruli in the inner portion of the cortex, as seen in Figure 1.
This permits evaluations of a relatively wide span of develop-
mental stages within a single tissue section.
Within the glomerulogenic zone, comprising a rim of cortical
tissue composed of metanephric blastema, branching termini of
the ureteric bud, glomeruli at the earliest stages of glomerulo-
genesis (vesicle, comma, and S-shaped glomeruli) and a primi-
tive vasculature organized in arcades. Expression of PDGF
B-chain was localized to differentiating cells of glomeruli vesi-
des and the epithelia of primitive glomeruli immediately adja-
cent to the ureteric bud. PDGF B-chain was not detected in the
adjacent mesenchyme, blastema and blood vessels, and gener-
ally not detected in the ureteric bud. PDGFR/3, in contrast, was
not detected within the primitive glomeruli but was abundantly
expressed by the metanephric blastema and interstitial tissues
surrounding glomeruli within the nephrogenic zone. The highest
level of cell proliferation, as detected by staining for PCNA,
was identified in this zone. Proliferating cells could most often
be identified as epithelial cells in the earliest stages of glomer-
ulogenesis and as metanephnc blastemal cells. This suggests
that PDGF released by primitive glomerular cells could be
having a paracrine effect on the surrounding PDGFRI3 positive
primordial interstitial cells. Within the glomerulogenic zone,
cells exhibiting features of muscle cell phenotype (positive for
muscle actin) and endothelial phenotype (positive for F111
related antigen and Ulex lectin) were confined to the intersitital
vasculature.
In more mature glomeruli located outside of the zone of
glomerulogenesis, the glomerular tuft architecture assumes a
more adult form and expression of PDGF B-chain, PDGFR/3,
and muscle-specific actin within the glomerulus is prominent
and restricted to the mesangial areas. The expression of muscle-
specific actin by developing mesangial cells appeared to occur
concurrently with identification of an organized intraglomerular
vasculature having contiguity with the extraglomerular intersti-
tial vasculature (as detected by staining for the markers of
endothelium). These patterns of glomerular expression contin-
ued to be present throughout the period of development (to day
105) encompassed by this study. In normal adult kidneys low
levels of PDGFR/3 are still expressed by mesangial cells [37],
but smooth muscle actin levels are greatly reduced [30], and
expression of PDGF B-chain can no longer be detected by
immunohistochemical techniques. The time at which fetal
mesangium converts to an adult phenotype remains to be
determined.
In the developing glomerulus, particularly in early stages of
glomerulogenesis, the cell lineage of specific cells can be
diflicult to ascertain on histologic grounds alone. The histologic
evidence that it is the mesangial cells which express PDGF
B-chain and PDGFR/3 in more mature glomeruli is supported by
the congruent pattern of immunocytochemical localization of
a-smooth muscle actin. By contrast, the endothelial cell-spe-
cific marker Ulex lectin stains cells with a distribution expected
for glomerular endothelial cells. The immunoelectronmicro-
scopic results confirm, at a higher level of resolution, that
a-smooth muscle actin and PDGFR/3 are both expressed by
cells in mesangial locations and neither are expressed by cells in
endothelial locations. We therefore propose that a-smooth
muscle actin is a marker for developing mesangial cells. A
particularly noteworthy feature of this muscle-specific protein
is that it is expressed at very low levels by mesangial cells in
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Fig. 2. Human fetal kidney, approximately 86 days gestation. A. PDGF-B chain is detected in early vesicle and comma- to S-shaped glomeruli
(EG), while blastema and ureteric buds are negative. More differentiated glomeruli (G) show mesangial pattern of expression. A tubular segment
(T) between a glomerulus and uretenc bud also expresses PDGF-B chain. 125x. B. Higher power view of early glomeruli seen in A. Staining of
differentiating epithelium which will become organized into a glomerular tuft, as well as epithelial cells which will become the parietal epithelial
cells lining Bowman's capsule, for PDGF-B chain is evident. 250x. C. Differential-d glomerular tuft showing mesangial localization of PDGF-B
chain. There is uniform staining of parietal epithelial cells lining Bowman's capsule. 250x. D. Paraformaldehyde fixed tissue, from same kidney
as shown in A through C, stained for PDGFR/3. There is localization of PDGFR/3 to blastema, vascular structures (present in arcades of interstitial
tissue), interstitial cells, and mesangial areas (arrows) of more mature glonieruli. 60X. E. Differentiated glomerulus stained for PDGFR/3. Staining
is confined to mesangial areas and extraglomerular interstitium. 250x. F. Differentiated glomerulus stained for PDGFR/3. In addition to mesangial
expression of this protein, occasional staining seemed to extend to glomerular capillary endothelium (arrows). 250x.
normal mature human glomeruli, and its expression is dramat-
ically upregulated in rat [291 and human [30] glomeruli in
response to injury.
Nonetheless, there are some limitations in our ability to
definitively state that PDGF and PDGF-R are expressed only by
mesangial cells. Immunostaining with antibody to F111-re1ated
antigen, an antigen that is generally considered to be expressed
exclusively by endothelial cells, reveals a pattern of localization
in fetal glomeruli in later stages of development that can be
indistinguishable from that of a-smooth muscle actin, PDGF,
i1
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Fig. 3. Same fetal kidney illustrated in Figure 2. A. Expression of a-smooth muscle actin, There is localization in vessels coursing through the
blastema, arterial and arteriolar smooth muscle cells (arrows) and in the mesangium in later stages of glomerular development (G). 60X. B. Higher
power view of a-smooth muscle actin expression in mesangium and in adjacent arteriolar smooth muscle cells (arrow). 250x. C. Expression of
Factor VIII related antigen also appears to have a mesangial rather than pure endothelial pattern. These findings present a paradox, suggesting in
the fetus that there are glomerular (apparently mesangial) cells with features of both endothelial and smooth muscle derivation. 250x. 0. Binding
of Ulex I lectin contrasts with that of Factor VIII related antigen in clearly exhibiting an endothelial pattern of reactivity including glomerular
capillary walls and interstitial vessels and capillaries. 125x. E. Staining for proliferating cell nuclear antigen (PCNA), indicative of repllcating cells,
is concentrated in blastema and in epithelial cells comprising early glomeruli in zone of glomerulogenesis. Positively stained cells are less numerous
but still present in more differentiated glomeruli as well as developing tubules and interstitium. 60x.
and PDGF-R. There are at least two possible explanations for
this. (1) The first possibility is that mesangial cells originate
from a mesenchymal precursor with some properties of both
endothelial cells (F,111 related antigen) and smooth muscle cells
(a-smooth muscle actin) and that expression of F111 is lost
relatively late in mesangial cell differentiation. (2) A second
possibility is that the apparent F511 staining of mesangial cells
is an artifact resulting from a close apposition of endothelial
cells to the mesangium, with regional concentration of F111
related antigen in those parts of the endothelial cells (nucleus
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Fig. 4. Ultrastructural immunolocalization of
PDGFRI3. Black peroxidase reaction product
is confined to the cell membranes of cells
within mesangial areas (M). Visceral epithelial
cells (V), and capillary endothelium (E) are
not reactive. C, capillary lumen. 8800x.
and large parts of the cell body) adjacent to the mesangial cells,
rather than distributed in the thin layers of fenestrated endo-
thelium which line the peripheral parts of the glomerular
capillary wall. Such a distribution would explain why the other
endothelial cell marker, Ulex europaeus I lectin, did not show a
mesangial staining pattern, since Ulex binds to an aL-fucose
carbohydrate moiety distributed diffusely over the surface of
the endothelial cell [341 rather than to a cytoplasmic compo-
nent. Resolution of this issue may come when we or others
develop the ability to successfully combine markers for F111
related antigen, actin, and PDGF-R in single sections studied by
immunoelectron microscopy.
The spatial and chronological patterns of expression of PDGF
B-chain and PDGFR/3 in the developing metanephric kidney
suggest that this growth factor/receptor interaction might have
multiple roles in the process of glomerular differentiation and
maturation. At the earliest stages of glomerulogenesis, PDGF
B-chain is expressed by the vesicle while the PDGFRJ3 is
expressed only outside the vesicle by blastemal and connective
tissue elements. This suggests a possible paracrine interaction
within the kidney, in which PDGF from the vesicle may
modulate the processes of glomerular induction or begin to
stimulate migration of receptor-positive cells from the vascular!
connective tissue into the glomerular cleft where they develop
into the mesangial stalk. There is growing evidence that PDGF
can act as such a migratory chemotactic factor for fibroblasts
[38], smooth muscle cells [39—40] and even mature mesangial
cells [41]. Once the mesangial-like cells have entered the
glomerulus they continue to express PDGFR/3 but now also
express PDGF B-chain. This might provide an autocrine stim-
ulus for further mesangial cell proliferation, migration, and/or
modulation. Eventually, expression of both PDGF B-chain and
PDGFR/3 is downregulated, further proliferation virtually
ceases, and the glomerulus achieves its mature/adult pheno-
type.
The autocrine phase of development may be reactivated in
adults under pathological conditions in which mesangial cell
proliferation is reactivated. We have recently provided evi-
dence that induced expression of PDGF B-chain and PDGFRI3
may mediate mesangial cell proliferation and participate in
reconstitution of the mesangium following antibody-induced
mesangiolytic injury in the rat [17, 18]. In man, there is some
limited evidence that upregulation of PDGF-R may occur in the
course of some forms of glomerulonephritis [19] as well as
evidence that PDGF may localize to the mesangium in some
forms of mesangial proliferative glomerulonephritis [20, 42].
Furthermore, it has been demonstrated that cultured mesangial
cells stimulated by a variety of mediator substances known to
participate in renal injury will produce PDGF [16, 43, 44]. It is
particularly noteworthy that in both the rat [17, 29] and humans
[30], this apparent upregulation of the PDGF/PDGF receptor
system in disease states is associated with phenotypic modula-
tion by mesangial cells to increase expression of muscle-specific
actin, similar to that identified in fetal glomeruli. We believe
these lines of evidence demonstrate that the PDGF/PDGF
receptor system mediates at least in part the proliferative and
reparative phases of mesangial injury in experimental animals
and in humans. The data presented in this study therefore
suggests that this response to injury recapitulates a normal
process of mesangial development that occurs in utero.
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